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Summary
Background: Studies show that high phosphotidylinositol
3,4,5-trisphosphate (PIP3) promotes cytoskeletal rearrange-
ments and alters cell motility and chemotaxis, possibly
through activation of protein kinase Bs (PKBs). However, che-
motaxis can still occur in the absence of PIP3, and the identi-
ties of the PIP3-independent pathways remain unknown.
Results: Here, we outline a PIP3-independent pathway linking
temporal and spatial activation of PKBs by Tor complex 2
(TorC2) to the chemotactic response. Within seconds of stim-
ulating Dictyostelium cells with chemoattractant, two PKB
homologs, PKBA and PKBR1, mediate transient phosphoryla-
tion of at least eight proteins, including Talin, PI4P 5-kinase,
two Ras GEFs, and a RhoGap. Surprisingly, all of the sub-
strates are phosphorylated with normal kinetics in cells lacking
PI 3-kinase activity. Cells deficient in TorC2 or PKB activity
show reduced phosphorylation of the endogenous substrates
and are impaired in chemotaxis. The PKBs are activated
through phosphorylation of their hydrophobic motifs via
TorC2 and subsequent phosphorylation of their activation
loops. These chemoattractant-inducible events are restricted
to the cell’s leading edge even in the absence of PIP3. Activa-
tion of TorC2 depends on heterotrimeric G protein function
and intermediate G proteins, including Ras GTPases.
Conclusions: The data lead to a model where cytosolic TorC2,
encountering locally activated small G protein(s) at the leading
edge of the cell, becomes activated and phosphorylates
PKBs. These in turn phosphorylate a series of signaling and
cytoskeletal proteins, thereby regulating directed migration.
Introduction
Chemotaxis, the directed movement of cells along chemical
gradients, is a fundamental cellular response critical to
*Correspondence: pnd@jhmi.edunumerous biological processes, including embryogenesis, in-
flammation, and wound healing. An understanding of chemo-
taxis could lead to treatments for inflammatory diseases as
well as methods to control cancer metastasis. The basic issue
in chemotaxis is how shallow chemoattractant gradients dif-
ferentially bias pseudopod activity at the front and rear of the
cell to direct movement. Previous studies have shown that
chemoattractant receptors are uniformly distributed along
the membrane but that activation of signaling pathways can
be confined at the cell’s leading edge. Current research is
focused on the mechanisms that spatially restrict signaling
and on the events that link local activation to regulation of
the cytoskeleton.
Dictyostelium discoideum is the most extensively character-
ized model system for chemotaxis, and its study has provided
important insights into the process in highly motile cells such
as leukocytes. Chemoattractant signaling triggers a series of
stereotypical reactions that regulate cell motility, polarity, and
directional sensing. One well-studied reaction is accumulation
of phosphatidylinositol 3,4,5-trisphosphate (PIP3) [1]. InD. dis-
coideum, PIP3 accumulation occurs at the front of chemotax-
ing cells because phosphoinositide 3-kinase (PI3K) is recruited
to the membrane facing the chemoattractant source and PTEN
dissociates from this region [2, 3]. In pten2 cells, excess PIP3
diffuses back from the leading edge, causing the cells to extend
pseudopods around much of their perimeter and to lose polar-
ity. In neutrophils, chemoattractants similarly promote PIP3
accumulation at the leading edge, and forced elevation of PIP3
is sufficient to cause the cells to polarize (T. Inoue, personal
communication, and [4, 5]). Although these observations dem-
onstrate the involvement of PIP3 signaling in chemotaxis, stud-
ies suggest that there are additional pathways. For instance,
D. discoideum cells treated with the PI3K inhibitor LY294002,
as well as pi3k1-52 cells, in which all of the type I PI3Ks are dis-
rupted, are still able to carry out chemotaxis [6, 7]. Furthermore,
neutrophils from PI3Kg knockout mice are able to carry out
chemotaxis under certain conditions [8, 9]. Recently, it was
revealed that a pathway containing a phopholipase A2 (PLA2)
functions in parallel with the PIP3 pathway in D. discoideum
[10, 11]. Thus, it is likely that in most cells multiple pathways
participate in a network that mediates chemotaxis.
A critical regulator of chemotaxis, found through genetic
analysis in D. discoideum, is Pianissimo (PiaA), now known
to be a component of the ‘‘Tor complex 2’’ (TorC2) [12, 13].
PiaA and other subunits, Rip3 and Lst8, are the orthologs of
mammalian Rictor, mSin1, and mLst8, respectively, and form
a complex with a unique Tor kinase [13]. TorC2 may also reg-
ulate cytoskeletal-based events in other cells. In cultured cells,
knockdown of a subunit of TorC2 altered cell morphology, in-
dicating that it may regulate the actin meshwork [14, 15].
Knockout mice lacking TorC2 subunits die in embryogenesis,
although fibroblasts from these embryos did not show cyto-
skeletal defects [16, 17]. In addition, TorC2 controls cell-cy-
cle-dependent actin polarization in budding yeast [18]. One
biochemical role of TorC2 is phosphorylation of the hydropho-
bic motifs (HMs) of protein kinase Bs (PKBs) and PKCs [15, 19].
In knockout mice of mSin1, Rictor, or Lst8 [20], the hydropho-
bic motif of AKT1 was not phosphorylated [16, 17, 21].
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required for phosphorylation of all PKB substrates in vivo.
D. discoideum has two PKB homologs, PKBA and PKBR1
[22, 23]. Whereas PKBA has a PIP3-specific pleckstrin homol-
ogy (PH) domain at its N-terminus like the mammalian PKBs,
PKBR1 is myristoylated, persistently localized on the mem-
brane, and relatively independent of PIP3. Otherwise, the two
enzymes are highly homologous to mammalian PKBs, includ-
ing within the activation loops (ALs) and the HMs. Cells lacking
PKBA are reported to have a weak chemotaxis defect in early
development [22]. Whereas pkbR12 cells arrest development
after aggregation, they are reported to have little defect in
chemotaxis [13, 23]. However, in light of the observations of
PIP3-independent chemotaxis, we examined the role of
TorC2 and PKBR1 in more detail. These studies led us to
a PIP3-independent pathway by which receptor-mediated
G protein stimulation leads to activation of TorC2 and phos-
phorylation of the HMs in the PKBs. Our findings show that
activation of TorC2 involves a Ras GEF and an intermediate
G protein and occurs selectively at the leading edge of the
cell. Importantly, we find that PKB substrates include Talin
B, several Ras GEFs, a RhoGAP, and PI4P 5-kinase, providing
possible links to the cytoskeleton.
Results
Role of TorC2 and PKBR1 in Chemotaxis
To assess the role of TorC2 and PKBR1 in chemotaxis, we
assessed the ability of disruptants to respond to a gradient
formed by a cyclic AMP (cAMP)-filled micropipette (Figure 1,
Movies S1, S2, and S3 available online). Wild-type cells re-
sponded to the gradient whereas most pkbR12 cells ignored
the gradient and crawled randomly. Compared to wild-type
cells, the pkbR12 cells had a greatly reduced chemotactic
index in spite of a slightly increased speed (Figure 1B and
Table 1). Interestingly, detachment of the fronts from the cover-
slip, a rare phenomenon in wild-type cells, was very prevalent
in pkbR12 cells (see Movies S1 and S2). Together, these results
show that pkbR12 cells have a strong chemotaxis defect that
may involve a problem in adhesion. We noted that when
pkbR12 cells were cultured for several months, the chemotac-
tic behavior seemed to ameliorate somewhat, possibly as a re-
sult of upregulation of PKBA (data not shown and see below).
However, disruptants of PKBA alone showed little chemotac-
tic defect. We should note that our results conflict with pre-
vious descriptions of pkbA2 and pkbR12 cells [22, 23]. This is
possibly due to differences in strains or conditions used in the
respective laboratories; nevertheless, these differences have
important implications for the mechanism of PIP3-indepen-
dent chemotaxis as outlined below.
To show that the chemotaxis defects were specific, we
expressed PKBR1 in the pkbR12 cells. Vector-expressing
pkbR12 cells showed reduced directionality toward the micro-
pipette even after 30 min of exposure to the gradient
(Figure S1A, left and Movie S4). On the other hand, PKBR1-ex-
pressing pkbR12 cells showed significantly better chemo-
taxis, and most of the cells faced the micropipette during
this assay (Figure S1A, right and Movie S5). Interestingly, the
PKBR1-expressing cells took slightly longer than wild-type
cells to begin chemotaxis after the micropipette was placed,
and then they became hyperelongated. These were consistent
dominant effects of (over)expression of PKBR1, because the
same phenotypes were observed when PKBR1 was ex-
pressed in wild-type cells (Figure S1B and Movies S6 and S7).Because TorC2 is required for the activation of PKBR1, we
directly compared the phenotypes of fresh piaA2 and
pkbR12 cells in the same background. As previously reported,
the piaA2 cells displayed very impaired chemotaxis, with both
reduced speed and reduced chemotactic index (Figure 1,
Movie S3, and Table 1). The piaA2 cells had a rounded mor-
phology and lacked polarity, which to some extent distin-
guished them from the polarized pkbR12 cells [12, 13]. This
suggests that TorC2 may regulate other factor(s) in addition
to PKBR1 to establish polarity.
Chemoattractant-Mediated Phosphorylation
of PKB Substrates
To get at the origin of the chemotactic defects, we sought to
define the PKB substrates. We used antibodies directed
against the phosphorylated consensus motifs of PKB and a
variety of other kinases (as controls) to detect proteins modi-
fied after chemoattractant stimulation. Cell extracts were pre-
pared for immunoblot analysis at the indicated times after
stimulation (Figure 2A). For PKB, multiple bands appeared and
declined with different kinetics (Figure 2B). To display the rapid
kinetics more clearly, we took samples at closer intervals.
A number of early bands such as pp65/67 and pp90 peaked
within 20–60 s of cAMP addition (Figure 2B, right), marginally
slower than the activation of PKBA or PKBR1 reported previ-
ously [22, 23]. The slight delay may stem from our procedure
of keeping cells on ice to prevent them from spontaneously re-
sponding before stimulation (see Supplemental Experimental
Procedures). These signals were specific receptor-mediated
phosphorylation events. First, the other substrate phospho-
specific antibodies showed completely different patterns
(Figure S2A). In particular, for CDK, many phosphorylated pro-
teins were stained in resting cells, and this pattern did not
change substantially after stimulation. Second, there were no
bands appearing in the absence of stimulation (Figure S2B).
Third, in subcellular fractionation experiments, we noticed that
the signals were greatly reduced in the absence of phospha-
tase-inhibitor cocktails (data not shown).
The relative contributions of PKBA and PKBR1 to these che-
moattractant-induced phosphorylations were strongly corre-
lated with the chemotactic defects (or lack thereof) in the
pkbR12 andpkbA2 cells. As shown in Figure 2C, most proteins
were still phosphorylated in the pkbA2 cells, indicating that
PKBA is not primarily responsible for these modifications.
On the other hand, in pkbR12 cells, the signals from pp350,
pp280, pp200, pp180, pp110, pp90, and pp65/67 were strongly
reduced compared to those in wild-type cells (Figure 2D and
Figure S2C). In pkbA2/pkbR12 cells, the bands were further
reduced (data not shown), suggesting overlap of substrate
specificity. Some bands (i.e., pp30) were unaffected in either
single or double mutants, and we presume that these are not
PKB substrates. We next determined which bands were recov-
ered when PKBR1 was expressed in pkbR12 cells. Seven sig-
nals (pp350, pp280, pp200, pp180, pp110, pp90, and pp65/67)
were recovered, and an additional band, pp140, also appeared
(Figure S2D, right). These results identify eight putative sub-
strates of PKBR1 and/or PKBA in vivo and show that chemo-
attractant is an important regulator of these kinases.
Chemoattractant-Induced Phosphorylation of Talin, PI4P
5-Kinase, Two Ras Gefs, and a RhoGap
We identified five of the putative PKB substrates by using an
immunoprecipitation strategy followed by SDS gel separation
and mass spectrometry (Figure S3). One of the proteins,
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tides in mass spectrometry from the purified band (Figure 3
and Figure S3A). Importantly, Talin B (DDB0191526) contains
the specific consensus site (RIRGQTP) recognized by the anti-
body in a phosphorylation-dependent manner. Talin B was
present at the same levels in wild-type, pkbR12, and piaA2
cells (Figure 3B) and was specifically immunoprecipitated
with the phospho-PKB substrate antibody only in cells ex-
pressing PKBR1 and stimulated with cAMP (Figure 3C).
At pp180, we found a Ras GEF, GEFN (DDB0167277), contain-
ing the PKB motifs (RLRSFTP, RSRAQTP). At pp110, we found
another Ras GEF, GEFS (DDB0191324), containing the PKB
motifs (RVRHSTP, RIRSPSP) as well as a PI4P 5-kinase do-
main-containing protein (DDB0234212) containing the PKB
motif (RVRLNTP). At pp65/67, we found a RhoGAP-domain-
containing protein, GACQ (DDB0233774), containing the PKB
motif (RQRSNTP). For the latter three proteins, we validated
chemoattractant-mediated phosphorylation by expressing
corresponding GFP-fusion proteins in wild-type cells. In
each case, a new appropriately sized band appeared when
stained with phospho-PKB substrate antibody (Figure S3B).
This interesting set of proteins suggests mechanisms by which
chemoattractant-mediated PKB phosphorylation controls
signaling and cytoskeletal events that underlie chemotaxis.
Activation of the PKBs by TorC2 through Phosphorylation
in the Hydrophobic Motif
Studies in mammals and Drosophila indicate that PKBs have
one phosphorylation site in the AL and another in the HM that
Figure 1. Chemotaxis of Wild-Type, pkbR12, and
piaA2 Cells in the Micropipette Assay
(A) Wild-type (WT), pkbR12, and piaA2 cells were
spread on a coverslip and observed at 30 s inter-
vals for 30 min. Micropipette contains 10 mM
cAMP. First and last images are shown. Scale
bars represent 50 mm.
(B) Tracing of individual cells are shown.A indi-
cates the position of micropipette.
(C) Distributions of motility speed (black bar) and
chemotaxis speed (white bar) are compared
from (A).
are necessary for activity [19]. To con-
firm the importance of these sites, we
performed mutational analysis of each
in PKBR1 and examined whether the
mutant proteins could complement
the developmental defects of pkbR12
cells or support phosphorylation of the
endogenous substrates (Figures S4A,
S4B, and S4C). Substitution of AL
T309 with alanine or the phosphomi-
mics, aspartate or glutamate, produced
inactive enzymes in both assays, sug-
gesting that T309 is critical for function.
Substitution of alanine for HM T470
also yielded an inactive enzyme. How-
ever, PKBR1T470D and PKBR1T470E
complemented the developmental de-
fect and restored the normal pattern of
phosphorylation to the pkbR12 cells.
These results strongly suggest that
phosphorylation of T470 is important for the in vivo kinase
activity of PKBR1.
Since piaA2 andpkbR12 cells displayed similar chemotactic
defects and TorC2 has been reported to be necessary for
activation of AKT in Drosophila and mammalian cells, we
next investigated the role of TorC2 in activation of PKBA and
PKBR1. In cells lacking PiaA, the phosphorylations of endog-
enous PKB substrates were greatly reduced (Figure 2D and
Figure S2C). In order to show that PKBR1 was a TorC2
substrate, we examined phosphorylation of T470 directly.
We noticed that the epitope of the anti-phospho-PDK1 dock-
ing-motif antibody (F/K-X-X-F/Y-S/T-F/Y) matched closely
with HM of PKBR1 (FEGFTYVADS) and tested whether this an-
tibody could recognize T470 of PKBR1 in a phosphorylation-
dependent manner (Figure 4A). In pkbR12 cells expressing
PKBR1, the antibody selectively stained the protein after stim-
ulation (Figure S4D). The band was present in PKBR1WT and
PKBR1T309A but absent in PKBR1T470A (Figure S4E). The signal
in PKBR1T309A was consistently lower than in PKBR1WT, indi-
cating that T309 influences T470 phosphorylation. The staining
disappeared when PKBR1-HA proteins were immunoprecipi-
tated and treated with l phosphatase (Figure S4F). We also
detected a 75 kDa band—presumably phosphorylation at
T470 in endogenous PKBR1—during cAMP stimulation of
wild-type but not pkbR12 cells (Figure 4B). Most significantly,
T470 phosphorylation was completely absent in piaA2 cells
(Figure 4B), and it was reduced by over 75% in rip32 cells,
which lack another of the TorC2 subunits (Figure S4G). These
data strongly suggest that TorC2 is the kinase that
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sistently associated with the membrane, that the TorC2 is
activated by chemoattractant.
We also directly observed chemoattractant-induced phos-
phorylation at T309 of PKBR1 and T278 of PKBA conserved
activation loop, with the anti-phospho PKC (pan) antibody
that detects phosphorylation of the AL (Figure 4C). The larger
band disappeared in pkbR12 cells (Figure 4C), and both bands
were absent in pkbA2/pkbR12 cells (data not shown). These
phosphorylations peaked at 30 to 60 s, kinetics nearly identical
to those of the HM phosphorylation of PKBR1 by TorC2 (Fig-
ures 4B and 4C). Curiously, we noticed that the AL phosphor-
ylation of PKBA was increased in pkbR12 cells compared to
wild-type cells, suggesting that it depends on a balance
between the amount of PKBR1 and PKBA (Figure 4C, long
exposure).
It has been shown that mammalian PKBs can, under some
circumstances, be phosphorylated in the AL independently
of TorC2, and therefore we asked whether or not this is the
case for each PKB in D. discoideum [16, 17, 21]. As shown in
Figure 4C, the phosphorylation of PKBR1 completely disap-
peared in piaA2 cells, whereas that of PKBA was decreased
but still weakly remained at 30 s (Figure 4C, long exposure).
To further confirm the effect of the HM phosphorylation on
Table 1. Quantification of Cellular Behavior
Strain
Motility Speed
(mm/min) Chemotactic Index
AX-3 (wild-type) 4.9 6 1.5 (n = 51) 0.65 6 0.24
pkbR12 5.3 6 2.2 (n = 48) 0.04 6 0.35
piaA2 3.7 6 1.1 (n = 52) 0.31 6 0.28
Motility speed and chemotactic index are calculated by the definition in the
Supplemental Experimental Procedures. Error bars represent standard
deviation.the AL phosphorylation, we used PKBR1T470A. Consistently,
after cAMP stimulation, the anti-phospho PKC (pan) antibody
stained neither PKBR1T470A nor PKBR1T309A, whereas PKBR1
was stained strongly (Figure 4D). These results suggest that
the phosphorylation in the HM is a strict prerequisite for AL
phosphorylation in PKBR1, whereas it enhances AL phosphor-
ylation in PKBA.
Activation of PKBR1 by TorC2 Is Independent of PIP3
The kinetics of T470 phosphorylation and activation of PKBR1
by TorC2 are essentially identical to those for chemoattrac-
tant-induced accumulation of PIP3; however, PKBR1 activity
measured in vitro is stimulated by cAMP in pi3k1-22 cells [23].
We used pi3k1-52 quintuple-knockout cells [7] and LY294002
to ask whether activation of TorC2 and PKBR1 in vivo against
endogenous substrates required PIP3. Anti-phospho-PKB
antibody detected nearly the same level of phosphorylation
of pp350, pp200, pp180, and pp110 in pi3k1-52 compared to
wild-type cells, whereas the phosphorylation of pp90 and
pp65/67 were reduced slightly (Figure 4E, upper left). Acute
treatment with PI3K inhibitor LY294002 (30 mM) also reduced
the signals only slightly (Figure 4E, upper right). These small
reductions are probably caused by a failure to activate PKBA
activity (see below), and the results suggest that PKBR1 acti-
vation is largely independent of PIP3.
Next we assessed whether TorC2 activity is regulated by
the PIP3 pathway by monitoring T470 phosphorylation. Again,
there were no significant differences between wild-type and
pi3k1-52 cells (Figure 4E, middle left). Surprisingly, 30 mM
LY294002 reduced T470 phosphorylation of PKBR1 by about
50% (Figure 4E, middle right). Considering the lack of depen-
dence on PI3-kinases, we suggest that this is because
LY294002 can directly inhibit TorC2 activity [20]. These results
further suggest that the TorC2-PKBR1 pathway is indepen-
dent of PIP3. Because unlike other PKBs, PKBR1 is persis-
tently present on the membrane whereas phosphorylation ofFigure 2. The TorC2-PKBR1 Pathway Regulates
a Major Portion of Dictyostelium PKB Activity
(A) Outline of experimental procedure is shown.
Differentiated cells were stimulated with 1 mM
cAMP and sampled for immunoblot analysis at
the indicated time points. All gels were analyzed
with a-phosphospecific PKB substrate antibody
that recognizes R-X-R-X-X-S/T-X-X in a phos-
phorylation-dependent manner (R, arginine; S,
Serine; T, threonine; X, any amino acid).
(B) The left panel is a time course to 11 min with
molecular-weight markers. The right panel is
a time course to 120 s with major phosphopro-
teins marked.
(C) Comparison of WT and pkbA2 cells is shown.
(D) Comparison of WT, pkbR12, and piaA2 cells
is shown.
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(A) Talin B is schematically represented. The FERM, I/LWEQ, and villin head
piece (VHP) domain are shown. Four peptides were identified by mass-
spectrometry analysis. RIRGQT is the site recognized by a-phosphospecific
PKB substrate antibodies. Talin B also has other plausible PKB phosphory-
lation sites (KKRKDT and RKKEYS).
(B) Whole-cell extracts (WCE) from WT, pkbR12, and piaA2 cells were
stained with a-Talin B antibody.
(C) pkbR12 cells carrying vector (V) or PKBR1-HA plasmid were stimulated
with 1 mM cAMP, and cell extracts were prepared (WCE). Immunoprecipita-
tion (IP) was performed by a-phosphospecific PKB substrate antibodies,
and samples were immunoblotted with a-Talin B antibody.T470 increases and decreases, it appears that TorC2 is tran-
siently activated by chemoattractant.
We also directly assessed the dependence of the phosphor-
ylation of T309 of PKBR1 and T278 or PKBA on PIP3. For
PKBR1, there were no significant differences between wild-
type and pi3k1-52 cells (Figure 4E, lower left). In addition,
30 mM LY294002 caused a slight reduction (Figure 4E, lower
right), probably because LY294002 inhibits T470 phosphoryla-
tion (Figure 4E, middle right), which is required for T309 phos-
phorylation (Figures 4C and 4D). In both pi3k1-52 cells and
cells treated with LY294002, the phosphorylation of PKBA
was lost, suggesting that phosphorylation of the AL occurs
during its recruitment to the membrane (Figure 4E, lower left
and right).
To reveal whether the phosphorylation of T470 is sufficient
for full activation of PKBR1, we studied the phosphomimetic-
substitution T470E mutant further. As shown in Figure S4A,
T470E can complement the biological and biochemical
defects in pkbR12 cells. When starved pkbR12 cells carrying
PKBR1T470E were stimulated, phosphorylations of endoge-
nous substrate were induced, although some bands were
slightly reduced compared to PKBR1WT (Figure S4H, left).
Both PKBR1WT and PKBR1T470E in pkbR1
2 cells were phos-
phorylated at T309 after cAMP addition, although the phos-
phorylation of PKBR1T470E was weaker and less sustained
(Figure S4I). Furthermore, chemoattractant-mediated changes
in phosphorylation of PKBR1T470E were observed with the
same kinetics in piaA2 cells (Figure S4I). However, this was
apparently not sufficient activation to cause full phosphoryla-
tion of the endogenous substrates (Figure S4H, right), and
PKBR1T470E did not suppress the development defects of
piaA2 cells (data not shown). These findings have several im-
plications. First, a role of TorC2 in addition to T470 phosphor-
ylation is required for full PKBR1 activation. Second, T309
phosphorylation must be regulated by yet another mecha-
nism in addition to PIP3 or T470 phosphorylation. D. discoi-
deum contains two PDK1-like enzymes. It is possible that
these enzymes act together with TorC2 to activate PKBR1.
Two GTP Binding Proteins Are Required
for TorC2 Activation
To further explore the pathway for activation of TorC2, we
devised a cell-free system. Cell lysates were stimulated with
GTPgS and incubated briefly, and the phosphorylation of
the HM and AL of PKBR1 and the phosphorylation of endoge-
nous PKB substrates were assessed. We monitored GTPgS-
mediated phosphorylation of PKBR1 as well as phosphoryla-
tion of endogenous substrate, pp 65/67 (Figure 5A, top and
bottom, respectively; data not shown). Consistently, phos-
phorylation of T309 or pp65/67 was not observed in piaA2
cells. However, both could be rapidly reconstituted by mixing
lysates of pkbR12 and piaA2 cells. This indicates that TorC2
present in the pkbR12 cell lysates can be activated and phos-
phorylate PKBR1 present in the piaA2 cell lysates. This is
consistent with previous data showing that wild-type superna-
tants can reconstitute adenylyl cyclase activation to lysates
from piaA2 cells prestimulated with cAMP or GTPgS [12, 13].
The cell-free system, together with the assays of phosphor-
ylations mediated by chemoattractant in living cells, allowed
us to explore the pathway for TorC2 activation more directly.
In intact cells, chemoattractant-induced phosphorylations
of either PKBR1 or PKBA HMs or ALs were strictly dependent
on functional heterotrimeric G proteins because these modifi-
cations were completely absent in cells lacking the unique Gb
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phorylations in the Hydrophobic Motif by TorC2
and in the Activation Loop Independently of PIP3
(A) Schematic representation of PKBR1 shows
detection of phosphorylation at T309 and T470
by the a-phospho PKC (pan) antibody and
the a-phospho PDK docking-motif antibody,
respectively.
(B) WT, pkbR12, and piaA2 cells were stimulated
with 1 mM cAMP, and cell extracts taken at the in-
dicated times were probed with a-phospho PDK
docking-motif antibody. The protein-transferred
membrane was stained with Coomassie brilliant
blue (CBB) as a loading control.
(C) Cell extracts were prepared as in (B) and were
probed with a-phospho PKC (pan) antibody.
Shorter and longer exposures are shown.
(D) Cell extracts expressing PKBR1(WT),
PKBR1(T309A), or PKBR1(T470A) tagged with
HA in pkbR12 were prepared at the indicated
times after 1 mM cAMP and probed with a-phos-
pho PKC (pan) antibody. a-HA was used to detect
expression of each PKBR1 proteins.
(E) For evaluation of PIP3 dependency of TorC2-
PKBR1 pathway, wild-type (WT) and pi3k1-52
cells (in the left panel) and WT cells treated with
or without 30 mM LY294002 (in the right panel)
were used. Cell extracts were prepared as in
(B). PKBR1 and TorC2 activity were detected
with a-phosphospecific PKB substrate antibody
(upper panel) and a-phospho PDK docking-motif
antibody (middle panel), respectively. The
a-phospho PKC (pan) antibody was used to
show the phosphorylation in the ALs of PKBR1
and PKBA (lower panel).present in D. discoideum (Figure 5B). However, in lysates from
gb2 cells, GTPgS was still able to activate TorC2, as evi-
denced by phosphorylation of T309 of PKBR1, although the
levels were somewhat reduced (Figure 5C). These observa-
tions suggest that activation of the heterotrimeric G protein
by chemoattractant is relayed to an intermediate G protein
in the pathway. In vitro, the heterotrimeric G protein can be
bypassed by direct activation of the intermediate G protein
by GTPgs.
One possibility is that the intermediate G protein or proteins
are Ras family members because these proteins have been
shown to be activated by chemoattractant [24–26]. The phos-
phorylation of PKBR1 was reduced by over 60% in cells lacking
the Ras GEF AleA, suggesting that a Ras-like G protein could be
involved in the pathway (Figure 5D). These results prompted us
to test cells lacking RasG or/and RasC. However, in the rasG2
cells, phosphorylation events in either in vivo or in vitro assays
were basically identical to those wild-type cells (data not
shown). On the other hand, in rasC2G2 cells, phosphorylation
of PKB substrates, the HM of PKBR1, and the ALs of PKBR1
and PKBA were significantly reduced (Figure 5E). Levels at
the HM of PKBR1 and the ALs of PKBR1 and PKBA were
reduced by 70%, 66%, and 38%, respectively. Together, these
data suggest that these Ras proteins play a role in TorC2
activation. However, because activity remains in the ras
C2G2 cells, additional intermediate G proteins must also be
involved.Local Activation of TorC2 and PKB at the Leading Edge
of Chemotaxing Cells
We wondered whether spatially localized activation of TorC2
and PKBR1 might account for their role in chemotaxis. For
investigation of TorC2 activation, phosphorylation of the AL
of PKBR1 was monitored by staining cells with the anti-
phos-PKC (pan) antibody. Cells were stimulated uniformly
with cAMP, and the time course of staining was assessed.
Consistent with the immunoblot analysis, there was a transient
burst of staining that appeared within 5 s of stimulation and
declined by 60 s (Figure 6A). This increase was absent in
PKBR1T470A cells, as expected (see Figures 4C and 4D). The
staining with an anti-HA antibody was uniform along the cell
perimeter and showed no time-dependent changes. These ob-
servations suggest that this staining reaction reflects the acti-
vation of TorC2 and can be used to monitor the distribution of
TorC2 activation in living cells. As shown in Figure 6B, the lead-
ing edge of chemotaxing cells were strongly and selectively
stained with this approach. These signals were below the level
of detection in wild-type cells (data not shown) and were ab-
sent in pkbR12 cells expressing PKBR1T470A (see Figure 4D).
Both PKBR1WT and PKBR1T470A are localized uniformly along
the membrane as detected by an anti-HA antibody (Figure 6B).
As a second ‘‘biosensor’’ for the activity of TorC2, we devel-
oped a molecular tool, R1-AKT-HA, in which the PH domain of
human AKT1 was replaced with the N terminus of PKBR1
(Figure 6C). Although R1-AKT-HA could not complement the
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cAMP stimulation it was phosphorylated in the HM as as-
sessed by an anti-phospho-AKT (S473) antibody in immuno-
blots (Figure S5B). This phosphorylation disappeared in
piaA2 cells, showing that R1-AKT-HA is phosphorylated by
TorC2 (Figure S5B) and that this antibody can be used to
explore the spatial pattern of activation of TorC2. Whereas
wild-type cells did not show any significant staining with the
anti phospho-AKT (S473) antibody, R1-AKT-HA-expressing
cells were stained selectively at the leading edge (Figure 6C).
When stained with anti-HA antibody R1-AKT-HA was localized
uniformly along the membrane like PKBR1, as expected
(Figure 6B). These observations suggest that, although
TorC2 is found largely in the cytosol, it is selectively activated
by chemoattractant stimulation and at the leading edge of
chemotaxing cells.
Discussion
Our observations define a pathway linking chemoattractant re-
ceptors through activation of TorC2 and PKBs to regulation of
Figure 5. Two GTP-Binding Proteins Are Re-
quired for TorC2 Activity
(A) Cell lysates from indicated strains were acti-
vated with GTPgS, and T309 phosphorylation of
PKBR1 was evaluated with the a-phospho PKC
(pan) antibody. The intensity of each band was
quantified from five independent experiments.
Error bars represent standard deviation. For
PKB activity, cell extracts were probed with a-
phosphospecific PKB substrate antibody.
(B) WT and gb2 cells were stimulated with 1 mM
cAMP, and the phosphorylation level in the HM
of PKBR1(T470) and the AL of PKBR1(T309) and
PKBA(T278) was assessed by the a-phospho
PDK docking-motif and a-phospho PKC (pan)
antibodies.
(C) Stimulation of cell lysates from WT and gb2
cells with GTPgS were performed in as (A).
(D) The T470 phosphorylation of PKBR1 in WT
and aleA2 cell was compared. The quantification
is the average of three experiments.
(E) Phoshorylation of PKB substrates, the HM of
PKBR1, and the AL of PKBR1 and PKBA in WT
and cAR1-expressing rasC2G2 cells were com-
pared. The quantification is the average of three
experiments.
the cytoskeleton at the cell’s leading
edge. Figure 7 summarizes these find-
ings. Chemoattractant binds to the
surface receptor and activates the heter-
otrimeric G protein. The activated G pro-
tein signals through a Ras GEF to inter-
mediate G proteins, including RasC.
We speculate that activation of the inter-
mediate G proteins is confined to the
front of the cell, leading to spatially re-
stricted activation of TorC2 and PKBR1.
Chemoattractant also triggers to local
accumulation of PIP3 at the front, as pre-
viously described. PKBA is recruited
to the front through its PIP3-specific
PH domain, and TorC2 enhances its
activation. These events result in chemoattractant-mediated
phosphorylation of Talin B and other signaling proteins, pro-
viding a possible link to the cytoskeleton.
Combined genetic and biochemical analyses show that
there is an intermediate G protein involved in activation of
TorC2. In intact cells, activation of TorC2 by chemoattractant
assessed by phosphorylation of HM and AL sites, as well as
phosphorylation of endogenous substrates, requires hetero-
trimeric G protein function. In cells lacking the Ras GEF
AleA, the activation is attenuated. However, in a cell-free sys-
tem, GTPgS activates TorC2 in the absence of heterotrimeric
G protein function, indicating that a second intermediate
G protein is involved. It has been reported that because
RasG interacts with Rip3 in yeast two-hybrid assays, RasG
activates TorC2 [13, 25, 27]. Our results indicate that the mech-
anism is more complex. First, whereas rip32 cells are signifi-
cantly impaired, some activation still occurs in the absence of
Rip3. Second, our results suggest that RasC, together with
AleA, plays a role in the activation because cells lacking
RasG show no defect whereas those lacking RasG and RasC
show a partial defect. This suggests that an additional inter-
mediate G protein is also required. Further investigation
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stimulation are different Ras family members, a combination
of Ras proteins, or as-yet-undetermined G proteins and also
whether other subunits of TorC2 besides Rip3 participate in
the activation.
How might the temporal and spatial regulation of TorC2
activity be mediated? Our studies of the persistently mem-
brane-associated PKBR1 force us to consider schemes that
do not involve PKB recruitment. We speculate that cytosolic
Figure 6. The Activity of TorC2 and PKBR1 Is
Spatially Regulated in Chemotaxing Cells
(A) Schematic representation of PKBR1 shows
phosphorylation of T309 detected by a-phos-
PKC (pan) antibody. pkbR12 cells expressing
PKBR1(WT)-HA or PKBR1(T470A)-HA were fixed
at the indicated times after cAMP stimulation and
stained with a-phos-PKC (pan) or a-HA antibody.
(B) The same cells as (A) were allowed to perform
chemotaxis and stained with a-phos-PKC (pan)
antibody to detect the phosphorylation of T309
of PKBR1 or a-HA antibody for the localization
of PKBR1.
(C) Schematic representation of chimera R1-
AKT-HA shows phosphorylation at serine (S473)
detected by a-phos-AKT (S473) antibody. Cells
were treated as in (B) and stained with a-phos-
AKT (S473) antibody to detect the phosphoryla-
tion of S473 or a-HA antibody for the localization
of R1-AKT-HA. Arrowheads show localized
staining. Scale bars represent 10 mm.
TorC2 encounters membrane-associ-
ated activators, such as the intermediate
G protein(s), at the leading edge and
phosphorylates PKBR1 (and PKBA) be-
fore TorC2 returns to the cytosol [28]. It
has been shown that RasG and RasC
are activated by chemoattractants and
that the Ras-binding domain of Raf lo-
calizes selectively to the front of chemo-
taxing cells [25]. However, as noted
above, cells lacking RasG and RasC still
activate PKBR1. Therefore, we seek an
additional locally activated intermediate
G protein.
Significantly, one of the PKB sub-
strates we have identified is Talin B,
and we have traced a pathway from
chemoattractant stimulation to Talin B
phosphorylation. Furthermore, we spec-
ulate that Talin B is selectively phos-
phorylated at the leading edge of the
cell because TorC2 is active there. Cells
lacking Talin B display a developmental
phenotype similar to cells lacking
PKBR1 in that they arrest as late aggre-
gates [29, 30]. Talin controls cell attach-
ment to the substratum by interacting
with integrins, and D. discoideum cells
expresses a series of primitive integrins
that regulate cell adhesion and interact
with Talin [31]. Interestingly, we find
that the effect of loss of PKBR1 activ-
ity on chemotaxis seems to include
a reduction in cell attachment to the substrate. However, it
remains to be determined whether Talin B, and its phosphory-
lation, regulates cell adhesion or other cytoskeletal events.
Furthermore, the other PKB substrates we have identified no
doubt also participate in aspects of chemotaxis.
The chemotactic signaling pathways are remarkably resil-
ient. Links from PIP3, localized at the cell’s leading edge, to
the cytoskeleton have been abundantly documented in D. dis-
coideum and in mammalian cells. Evidence suggests that
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ever, an equally strong body of evidence shows that cells can
carry out chemotaxis without PIP3. For D. discoideum, these
two apparently conflicting observations can be resolved by
the scheme shown in Figure 7. We speculate that responses
to excessive PIP3 are mediated by PKBA. In the absence of
significant changes in PIP3 levels, endogenous PKB sub-
strates still undergo transient phosphorylation as a result of
the chemoattractant-mediated activation of TorC2 and
PKBR1 we have described here. If the phosphorylation events
are blocked by removal of the PKBs (PKBR1 is predominant) or
TorC2, chemotaxis is greatly impaired. Thus, in wild-type cells,
the temporal and spatial pattern of the endogeneous phos-
phorylation events is controlled redundantly by local changes
in PIP3 and/or by local activation of TorC2.
Previous reports have suggested physiological roles for
TorC2 and PKBs in regulation of the cytoskeleton in other cells,
consistent with our findings of a role in chemotaxis. In budding
yeast, TorC2 regulates actin-patch polarization via YPKs,
yeast PKB homologs [32, 33]. In HeLa cells and 3T3 fibro-
blasts, reduction of TorC2 activity affects the extent of poly-
merized actin in cells, leading to different morphological
changes [14, 15], and knockouts of TorC2 subunits in mice
are lethal [16, 17]. In a variety of cancer cells, alterations in
the activity of various PKB isoforms have been reported to
enhance or decrease motility, invasion, and metastasis [34].
Furthermore, it has been suggested that PKB, and its kinase
PDK1, are required for chemotaxis of endothelial cells during
vascular-vessel formation [35]. More directly, knockdown of
PKB as well as the actin-binding protein Girdin, a substrate
of PKB, in Vero fibroblasts impaired migration in wound-heal-
ing assays [36]. Signaling networks similar to the framework
outlined in Figure 7 may underlie these various observations.
What of the reports of PIP3-independent chemotaxis? The
scheme in Figure 7 implies that activation of TorC2 at the cell’s
leading edge acts redundantly with PIP3. The equivalent of
PKBR1 could be a standard, PH-domain-containing PKB
under unusual conditions when PIP3 levels are extremely low
Figure 7. Schematic Diagram of Signaling Events at the Leading Edge of
a Chemotaxing Cell
The chemoattractant, cAMP, signals through its cognate heterotrimeric G
protein and AleA to an intermediate G protein. We speculate that the inter-
mediate G protein is locally activated and that TorC2, which is largely in the
cytosol, transiently encounters it (bent arrows). The activated TorC2 then
phosphorylates PKBR1 and PKBA before returning to the cytosol. PKBR1
is a more predominant activity and completely dependent on TorC2 for
activation whereas PKBA is a minor activity and depends on recruitment to
PIP3 and TorC2 for activation (heavier or lighter bent arrows). Among PKB
substrates is Talin B, which provides a possible link to the cytoskeleton.or high and TorC2 would be the dominant regulator (see
[37]). Alternatively, TorC2 might act on another kinase such
as PKC, which might serve as the equivalent of PKBR1.
Chemotaxis is mediated by a network of signaling events,
and our results indicate that TorC2-PKB represents an impor-
tant pathway in addition to the PI3K and PLA2 pathways, which
have been shown to redundantly regulate chemotaxis [10, 11].
TorC2 activation is independent of both PIP3 and PLA2 (unpub-
lished data), indicating that there are three parallel pathways. It
will be interesting to learn whether simultaneous block of all
pathways leads to an even more severe phenotype. It is likely
that each of these pathways regulates a specific set of physi-
ological responses that mediate an aspect of chemotaxis.
Further understanding may require us to delineate these re-
sponses, understand how they act together in chemotaxis,
and assign pathways to each response.
Supplemental Data
Supplemental Data include Supplemental Experimental Procedures, five
figures, and seven movies and can be found with this article online at
http://www.current-biology.com/cgi/content/full/18/14/1034/DC1/.
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